Abbott Laboratories ROE 2010-2023 | ABT
Abbott Laboratories ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2023-12-31 | $5.72B | $38.83B | 15.14% |
2023-09-30 | $5.16B | $37.69B | 13.84% |
2023-06-30 | $5.16B | $37.40B | 14.00% |
2023-03-31 | $5.80B | $37.23B | 15.82% |
2022-12-31 | $6.93B | $36.91B | 19.11% |
2022-09-30 | $7.89B | $35.88B | 21.88% |
2022-06-30 | $8.55B | $36.72B | 23.93% |
2022-03-31 | $7.73B | $35.63B | 22.02% |
2021-12-31 | $7.07B | $36.02B | 20.42% |
2021-09-30 | $7.24B | $34.64B | 21.39% |
2021-06-30 | $6.38B | $34.03B | 19.26% |
2021-03-31 | $5.72B | $33.79B | 17.72% |
2020-12-31 | $4.50B | $33.00B | 14.29% |
2020-09-30 | $3.38B | $31.60B | 10.90% |
2020-06-30 | $3.11B | $30.80B | 9.99% |
2020-03-31 | $3.58B | $30.43B | 11.39% |
2019-12-31 | $3.69B | $31.30B | 11.67% |
2019-09-30 | $3.29B | $32.02B | 10.47% |
2019-06-30 | $2.90B | $31.89B | 9.29% |
2019-03-31 | $2.62B | $31.13B | 8.49% |
2018-12-31 | $2.37B | $30.72B | 7.64% |
2018-09-30 | $0.89B | $30.90B | 2.85% |
2018-06-30 | $0.93B | $30.77B | 2.95% |
2018-03-31 | $0.48B | $31.60B | 1.50% |
2017-12-31 | $0.48B | $31.10B | 1.51% |
2017-09-30 | $2.10B | $32.22B | 7.23% |
2017-06-30 | $1.17B | $31.79B | 4.46% |
2017-03-31 | $1.50B | $31.55B | 6.40% |
2016-12-31 | $1.40B | $20.72B | 6.73% |
2016-09-30 | $1.37B | $20.90B | 6.53% |
2016-06-30 | $2.28B | $20.80B | 10.82% |
2016-03-31 | $2.45B | $20.84B | 11.31% |
2015-12-31 | $4.42B | $21.33B | 20.18% |
2015-09-30 | $4.56B | $21.22B | 20.74% |
2015-06-30 | $4.52B | $23.13B | 20.14% |
2015-03-31 | $4.20B | $21.99B | 18.60% |
2014-12-31 | $2.28B | $21.64B | 9.95% |
2014-09-30 | $1.97B | $22.99B | 8.25% |
2014-06-30 | $2.40B | $23.70B | 9.96% |
2014-03-31 | $2.41B | $23.49B | 10.14% |
2013-12-31 | $2.58B | $25.27B | 10.94% |
2013-09-30 | $3.04B | $23.79B | 12.70% |
2013-06-30 | $4.02B | $22.43B | 16.22% |
2013-03-31 | $5.27B | $22.68B | 20.82% |
2012-12-31 | $5.96B | $26.81B | 22.93% |
2012-09-30 | $6.53B | $27.10B | 25.67% |
2012-06-30 | $4.89B | $24.57B | 19.69% |
2012-03-31 | $5.11B | $25.54B | 20.18% |
2011-12-31 | $4.73B | $24.53B | 18.84% |
2011-09-30 | $4.55B | $24.69B | 18.45% |
2011-06-30 | $5.14B | $26.47B | 21.54% |
2011-03-31 | $4.49B | $24.72B | 20.18% |
2010-12-31 | $4.63B | $22.77B | 21.71% |
2010-09-30 | $4.73B | $21.48B | 22.06% |
2010-06-30 | $5.31B | $20.00B | 24.84% |
2010-03-31 | $5.31B | $21.01B | 24.84% |
2009-12-31 | $5.75B | $23.19B | 27.87% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $193.473B | $40.109B |
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Stryker (SYK) | United States | $133.123B | 33.06 |
Medtronic (MDT) | Ireland | $111.139B | 15.73 |
EssilorLuxottica (ESLOY) | France | $102.775B | 0.00 |
Boston Scientific (BSX) | United States | $99.865B | 33.14 |
Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
Haleon (HLN) | United Kingdom | $38.831B | 30.04 |
ResMed (RMD) | United States | $28.562B | 28.56 |
Terumo (TRUMY) | Japan | $27.589B | 38.84 |
Zimmer Biomet Holdings (ZBH) | United States | $26.224B | 16.91 |
Baxter (BAX) | United States | $21.095B | 15.39 |
Koninklijke Philips (PHG) | Netherlands | $18.610B | 14.84 |
Insulet (PODD) | United States | $11.574B | 60.85 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.401B | 0.00 |
Demant (WILYY) | Denmark | $11.148B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.711B | 28.93 |
BellRing Brands (BRBR) | United States | $7.779B | 41.82 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Haemonetics (HAE) | United States | $4.146B | 21.20 |
Lantheus Holdings (LNTH) | United States | $4.027B | 10.40 |
Prestige Consumer Healthcare (PBH) | United States | $3.575B | 16.90 |
Envista Holdings (NVST) | United States | $3.561B | 13.57 |
Neogen (NEOG) | United States | $3.248B | 31.25 |
QuidelOrtho (QDEL) | United States | $3.142B | 11.41 |
Green Thumb Industries (GTBIF) | United States | $2.981B | 94.47 |
ICU Medical (ICUI) | United States | $2.433B | 18.32 |
TG Therapeutics (TGTX) | United States | $2.384B | 772.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.097B | 0.00 |
Owens & Minor (OMI) | United States | $2.036B | 19.54 |
Verano Holdings (VRNOF) | United States | $1.879B | 0.00 |
InMode (INMD) | Israel | $1.736B | 8.99 |
National Vision Holdings (EYE) | United States | $1.710B | 53.24 |
Agios Pharmaceuticals (AGIO) | United States | $1.633B | 0.00 |
AdaptHealth (AHCO) | United States | $1.499B | 11.28 |
LeMaitre Vascular (LMAT) | United States | $1.470B | 48.81 |
AtriCure (ATRC) | United States | $1.407B | 0.00 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
MacroGenics (MGNX) | United States | $0.888B | 0.00 |
Quanterix (QTRX) | United States | $0.834B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.820B | 0.00 |
Evolus (EOLS) | United States | $0.803B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.702B | 15.18 |
Canopy Growth (CGC) | Canada | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.543B | 0.00 |
Jin Medical (ZJYL) | China | $0.527B | 0.00 |
PetIQ (PETQ) | United States | $0.524B | 19.55 |
TerrAscend (TSNDF) | Canada | $0.521B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.520B | 11.26 |
OraSure Technologies (OSUR) | United States | $0.465B | 7.70 |
Biote (BTMD) | United States | $0.440B | 4.18 |
ZimVie (ZIMV) | United States | $0.431B | 26.53 |
Surmodics (SRDX) | United States | $0.402B | 43.40 |
Zynex (ZYXI) | United States | $0.397B | 45.74 |
Viemed Healthcare (VMD) | United States | $0.352B | 34.96 |
Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
Cerus (CERS) | United States | $0.315B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 14.91 |
TriSalus Life Sciences (TLSI) | United States | $0.245B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.230B | 0.00 |
Omeros (OMER) | United States | $0.218B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.199B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.182B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.173B | 0.00 |
High Tide (HITI) | Canada | $0.155B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
Fonar (FONR) | United States | $0.137B | 11.80 |
InterCure (INCR) | Israel | $0.116B | 19.61 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.110B | 0.00 |
FitLife Brands (FTLF) | United States | $0.107B | 20.86 |
Safety Shot (SHOT) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.083B | 45.50 |
Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.27 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.045B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.035B | 13.52 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |